Find information on thousands of medical conditions and prescription drugs.

Zometa

Zoledronate (Zometa®, Novartis) is a bisphosphonate, used to prevent osteoporosis and skeletal fractures, particularly in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia, particularly hypercalcemia of malignancy. It can also be helpful for treating pain from bone metastases. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Zafirlukast
Zagam
Zalcitabine
Zaleplon
Zanaflex
Zanamivir
Zantac
Zarontin
Zelnorm
Zerit
Zestoretic
Zestril
Zetia
Zevalin
Ziagen
Zidovudine
Zileuton
Ziprasidone
Zithromax
Zocor
Zofran
Zoladex
Zoledronic acid
Zolmitriptan
Zoloft
Zolpidem
Zometa
Zomig
Zonegran
Zonisamide
Zopiclone
Zosyn
Zovia
Zovirax
Zyban
Zymar
Zyprexa
Zyrtec
Zyvox

Administration

Usually 4 mg intravenously once a month when given for oncologic purposes. It is given once a year for treatment of osteoporosis.

Side effects

Side effects can include fatigue, anemia, muscle aches, fevers, and swelling in the feet or legs. Zoledronate can cause deterioration in renal function.

A rare complicaiton of zoledronate is osteonecrosis of the jaw. This has mainly been seen in patients with multiple myeloma treated with zoledronate (Durie et al 2005).

Contraindications

  • Poor renal function (e.g. creatinine>3 mg/dL)
  • Pregnancy

Reference

  • Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005;353:99-102. PMID 16000365.

Read more at Wikipedia.org


[List your site here Free!]



Zometa OK'ed for one indication, Novartis tries for another - Brief Article
Days after Novartis received FDA approval to market Zometa (zoledronic acid for injection) as a hypercalcemia treatment, the drug company filed an additional ...
Long-term bisphosphonate use may damage jaw
Prolonged use of bisphosphonate therapy can lead to osteonecrosis of the jaw--a previously unrecognized and potentially serious complication that can ...
Significant FDA Approvals in 2001
The most urgent task faced by the U.S. Food and Drug Administration (FDA) in the wake of the terrorist attacks on September 11, 2001, was to assure the availability of medical products for the trea
One-shot treatment for stronger bones
OSTEOPOROSIS Administered intravenously (I.V.), a potent bisphosphonate may effectively treat osteoporosis with only a single dose per year. A recent ...
Zoledronic acid: Annual IV may equal daily oral Tx for osteoporosis - Gyneology
Intermittent infusions of the biophosphate zoledronic acid in postmenopausal women--with dosages as far apart as 12 months--increase bone density and ...
A case study demonstrating superiority of a new compound over the gold standard
Some basic issues relevant for demonstration of superior efficacy are discussed with the case of the development of zoledronic acid 4 and 8 mg in hypercalcemia ...
Multimedia Available/FDA Approves Novartis Drug ZOMETA — Zoledronic Acid for Injection — for the Treatment of Cancer-Related Bone Complications
Business Editors & Health/Medical Writers ADVISORY...for FRIDAY (Feb. 22) NOTE TO EDITORS: Multimedia Assets Available With This Story Include ...
ADVISORY/FDA Approves Novartis Agent ZOMETA For Treatment of Hypercalcemia of Malignancy
Business Editors & Health/Medical Writers ADVISORY...for TUESDAY (Aug. 21) NOTE TO EDITORS: Multimedia Assets Available With This Story Include ...

Home Contact Resources Exchange Links ebay